Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart.

KA Youker, HK Hawkins, GL Kukielka, JL Perrard… - Circulation, 1994 - Am Heart Assoc
KA Youker, HK Hawkins, GL Kukielka, JL Perrard, LH Michael, CM Ballantyne, CW Smith…
Circulation, 1994Am Heart Assoc
BACKGROUND Acute inflammation may play a role in injury during reperfusion following
myocardial ischemia. Studies in vitro suggest that intracellular adhesion molecule-1 (ICAM-
1) mediates neutrophil adherence to cardiac myocytes and neutrophil-mediated injury. We
have shown cytokine activity in postischemic cardiac lymph sufficient to maximally express
ICAM-1 on myocytes and that ICAM-1 mRNA is found in the previously ischemic
myocardium early in reperfusion. METHODS AND RESULTS In the present study, we used …
BACKGROUND
Acute inflammation may play a role in injury during reperfusion following myocardial ischemia. Studies in vitro suggest that intracellular adhesion molecule-1 (ICAM-1) mediates neutrophil adherence to cardiac myocytes and neutrophil-mediated injury. We have shown cytokine activity in postischemic cardiac lymph sufficient to maximally express ICAM-1 on myocytes and that ICAM-1 mRNA is found in the previously ischemic myocardium early in reperfusion.
METHODS AND RESULTS
In the present study, we used in situ hybridization techniques to detect ICAM-1 mRNA and examine the cells of origin, relation to cell injury, and relation to inflammatory infiltration after 1 hour of ischemia and varying times of reperfusion. By 1 hour of reperfusion, ICAM-1 mRNA was detected in much of the ischemic myocardium, except in areas of contraction band necrosis. At 2 and 3 hours, a clear demarcation of necrotic areas surrounding ischemic areas of viable myocardium with ICAM-1 mRNA staining was present, and ICAM-1 mRNA staining increased with time. Nonischemic areas had no visible ICAM-1 mRNA staining in the first 3 hours. By 24 hours of reperfusion, ICAM-1 mRNA was present in both control and ischemic segments (excluding the necrotic areas) compatible with a generalized circulation of cytokines persistent at 24 hours. In the absence of reperfusion, ICAM-1 mRNA staining was not seen in the first 3 hours and was markedly reduced at 24 hours. The interface of viable and necrotic cells also contained the most extensive inflammatory infiltration.
CONCLUSIONS
Evidence is presented that induction of ICAM-1 mRNA has highly specific localization to ischemic but viable myocardium. Induction of ICAM-1 mRNA transcription in early reperfusion may render the viable "border zone" susceptible to neutrophil-induced injury.
Am Heart Assoc